Exploration of miR-22 inhibiting cervical cancer progression through suppressing TGF-β/Smad3 pathway by targeting TGFBR1
Figure 1. (A) The results of RNA expression level of miR-22, TGFBR1, TGF-β1 in cervical cancer tissue and adjacent tissue. (B) The results of protein expression level of TGFBR1, TGF-β1 and Smad3 in cervical cancer tissue and adjacent tissue.